Clinical evaluation of a dried commercially prepared microdilution panel for antifungal susceptibility testing of five antifungal agents against Candida spp. and Cryptococcus neoformans
- 31 October 2004
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 50 (2) , 113-117
- https://doi.org/10.1016/j.diagmicrobio.2004.06.013
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance programDiagnostic Microbiology and Infectious Disease, 2004
- Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of CandidaClinical Microbiology & Infection, 2004
- Has Antifungal Susceptibility Testing Come of Age?Clinical Infectious Diseases, 2002
- Clinical Evaluation of a Frozen Commercially Prepared Microdilution Panel for Antifungal Susceptibility Testing of Seven Antifungal Agents, Including the New Triazoles Posaconazole, Ravuconazole, and VoriconazoleJournal of Clinical Microbiology, 2002
- ANTIFUNGAL SUSCEPTIBILITY TESTINGInfectious Disease Clinics of North America, 2001
- Antifungal Susceptibility Testing: Practical Aspects and Current ChallengesClinical Microbiology Reviews, 2001
- International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance ProgramJournal of Clinical Microbiology, 2001
- In Vitro Antifungal Susceptibility TestingPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001